ArticleMedChemComm2017

Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

V von Manstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.